DUBLIN--(BUSINESS WIRE)--The "Acute Respiratory Distress Syndrome - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
Acute Respiratory Distress Syndrome - Pipeline Insight, 2019 offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Acute Respiratory Distress Syndrome development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline Products covered across the following Developmental Stages:
- Clinical
- Non-clinical
- Inactive: Discontinued and/or Dormant
Scope of the Report
- The report provides a snapshot of the pipeline development for the Acute Respiratory Distress Syndrome
- The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Acute Respiratory Distress Syndrome
- The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Acute Respiratory Distress Syndrome
- The report also covers the dormant and discontinued pipeline projects related to Acute Respiratory Distress Syndrome
Topics Covered
1. Report Introduction
2. Acute Respiratory Distress Syndrome Overview
3. Pipeline Therapeutics
- An Overview of Pipeline Products for Acute Respiratory Distress Syndrome
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
- Product Description
- Research and Development
- Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
- Product Description
- Research and Development
- Product Development Activities
7. Therapeutic Assessment
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
- Product Description
- Research and Development
- Product Development Activities
Companies Featured
- Alliance Pharmaceutical
- Altor Bioscience
- Apeptico
- Asubio Pharmaceuticals
- Athersys
- Biomarck Pharmaceuticals
- Chiesi Farmaceutici
- Debiopharm International
- Faron Pharmaceuticals
- FirstString Research
- GlaxoSmithKline
- LEO Pharma
- Ono Pharmaceutical
- Orbsen Therapeutics
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/9jpjg7/acute_respiratory?w=4
